Ozempic Can Curb Cravings in Alcohol Use Disorder, Landmark Trial Finds

Ozempic can help people who are battling alcoholism, a major new clinical trial has concluded.

People with alcohol use disorder taking semaglutide (Ozempic/Wegovy) had significantly fewer heavy drinking days compared to patients assigned a placebo, researchers reported May 2 in The Lancet. 

People on semaglutide also dr...

US on the Brink of Losing Measles-free Status, Study Warns

The United States is moving quickly toward losing its status as a measles-free nation, a new study says.

The nation has missed four of seven markers set by the U.S. Centers for Disease Control and Prevention (CDC) after experts declared measles eradicated in 2000, researchers report in The Lancet.

These include a surge in me...

FDA Green Lights Expanded Access to Pancreatic Cancer Drug, Daraxonrasib

The U.S. Food and Drug Administration (FDA) granted expanded access for the use of an experimental pancreatic cancer drug, daraxonrasib. 

This means the drug will be available for early access to those who previously received conventional treatment for metastatic pancreatic ductal adenocarcinoma (PDAC). A healthcare provider must requ...

Online Misinformation Adding To Americans' Skin Cancer Risk, Survey Finds

Misinformation is putting more than 16 million Americans at increased risk for skin cancer, a new American Academy of Dermatology (AAD) survey has concluded.

Nearly 3 in 5 Americans (57%) regularly use sunscreen, the annual Practice Safe Sun Survey found.

But more than 16 million adults say they’ve reduced or stopped using suns...

Social Media Videos, Easy Access Raise Risk of Teen Inhalant Use

New research is raising alarms about inhalants, which are often portrayed online as harmless while putting teens at real risk.

Two new studies point to a troubling pattern: Younger teens, especially girls, may be more vulnerable — and social media is a major source of exposure.

In one study, recently published in the Journ...